Rehmann Capital Advisory Group

Position in ARGX — Argenx SE

CIK 1633037 LANSING, MI

Position in ARGX

as of Jun 30, 2026 · filed Aug 20, 2026 Compact

Position Value

$204,109

-$96,110 QoQ

Shares Held

220

-38.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#373

of 506 holders

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Rehmann Capital Advisory Group holds $2,257,367 across 4 Biotechnology names. ARGX ranks #3 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,812	$1,129,854
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,846	$916,963
3	ARGX	Argenx SE This page	220	$204,109
4	JSPR	Jasper Therapeutics, Inc.	15,300	$6,441

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$204,109	220	-38.4%	Shares	Sole	2026-08-20
2025-12-31	$300,219	357	+24.4%	Shares	Sole	2026-03-04
2025-09-30	$211,679	287	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.